Method to Reduce Hepatoxicity of Fas-Mediated Apoptosis-Inducing Agents

摘要

The invention concerns a method to prevent or reduce adverse effects on liver of a patient treated with a Fas-mediated apoptosis-inducing agent, the method comprising the administration of a product preventing TNF receptors-mediated apoptosis of the liver cells.